The Schizophrenia Society of Canada Foundation (SSCF) and the Canadian College of Neuropsychopharmacology (CCNP) formed a partnership in 2017 to offer research support in the form of a stipend and travel award (to present research results at a future CCNP annual meeting) to a doctoral (PhD) and Masters (MSc) student pursuing biomedical research related to the cause of and interventions for schizophrenia and related psychosis.
All applicants were evaluated on a standardized grid, including assessing academic dossier and background, research project, significance to objectives of this award, research environment and letters of support. Three reviewers reviewed each file, and conflicts were identified to allow a transparent and nonbiased evaluation.
We wish to thank the review committee who donated their time to review the applications. The review committee consisted of:
Dr. Ridha Joober (CCNP President)
Dr. Philip Tibbo (SSCF Chair)
Dr. Patricia Boksa
Dr. Bill Honer
Dr. Tina Montreuil
Dr. Lena Palaniyappan
We are very pleased to announce the following graduate students who were successful in this award:
PhD (4 years support)
Franz Veru, McGill University, Montreal, Que., Canada
“Adipose tissue dysregulation through psychosocial risk factors in first-episode psychosis”
Supervisor(s): Dr. Ashok Malla and Dr. Srividya Iyer, McGill University, Montreal, Que., Canada.
MSc (2 years support)
T-Jay Anderson, Mount Saint Vincent University, Halifax, NS, Canada
“Noninvasive brain stimulation as treatment for auditory hallucinations in schizophrenia: transcranial magnetic stimulation v. transcranial direct current stimulation”
Supervisor: Dr. Derek Fisher, Dalhousie University, Halifax, NS, Canada
Tara Delorme, McGill University, Montreal, Que., Canada
“The interaction between circadian disruption and genetic risk factors for schizophrenia”
Supervisor: Dr. Nicolas Cermakian, McGill University, Montreal, Que., Canada.
In this issue
Article tools
Related Articles
Cited By...
- No citing articles found.